BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 2, 2017
View Archived Issues
Phase II data from IPROTECT1 trial presented for VAC-3S anti-HIV1 vaccine
Read More
AbbVie presents key events from the second quarter 2017
Read More
Astellas recaps pipeline highlights of first quarter of fiscal 2017
Read More
IMMU-132 induces durable responses in heavily pretreated patients with metastatic NSCLC
Read More
Shionogi reviews key regulatory and pipeline events of first quarter of fiscal 2017
Read More
FDA approves Nityr tablets for treatment of hereditary tyrosinemia type 1
Read More
Phase III trial shows HIV suppression with bictegravir/emtricitabine/tenofovir coformulation
Read More
Muscarinic M1 receptor modulator from Suven has no cholinergic side effects in animal models
Read More
First patient treated in phase II trial of Acceleron Pharma's ACE-083
Read More
Aptinyx begins phase II studies of NYX-2925
Read More
French researchers patent compounds for treating cancer
Read More
FDA awards fast track designation to oral pritelivir for HSV in immunocompromised adults
Read More
Celgene identifies antiproliferative compounds for AML
Read More
Arcus Biosciences divulges CD73 inhibitors
Read More
Teva presents laquinimod prodrugs for multiple sclerosis
Read More
Soluble guanylate cyclase activators presented by Bayer
Read More
Rockefeller University divulges FXIIa inhibitors
Read More
Lundbeck joins large study of genetic causes of MDD and bipolar depression
Read More
Wakamoto begins phase II study of WP-1303 in Japan
Read More
FDA approves Opdivo for MSI-H and dMMR metastatic colorectal cancer
Read More
Integrated BioTherapeutics obtains funding to develop pan-ebolavirus vaccine
Read More
Cellectar Biosciences enters collaboration with Avicenna Oncology
Read More
FDA grants priority review to acalabrutinib NDA
Read More
NeuroDerm to hold extraordinary shareholder meeting regarding acquisition by Mitsubishi Tanabe
Read More
Amygdala Neurosciences initiates phase Ib study of ALDH2 inhibitor
Read More
TG Therapeutics, FDA reach agreement on phase III studies of TG-1101
Read More
FDA approves Idhifa for R/R AML with IDH2 mutation
Read More
FDA approves Epclusa for use in hepatitis C patients co-infected with HIV
Read More